Guide de prise en charge des sequelles respiratoires post infection a SARS-CoV-2. Propositions de prise en charge elaborees par la Societe de Pneumologie de Langue Francaise. Version du 10 novembre 2020.

ANDREJAK, C.; COTTIN, V.; CRESTANI, B.; DEBIEUVRE, D.; GONZALEZ-BERMEJO, J.; MORELOT-PANZINI, C.; STACH, B.; UZUNHAN, Y.; MAITRE, B.; RAHERISON-SEMJEN, Chantal

doi:10.1016/j.rmr.2020.11.009

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

Langue

Article de revue

Ce document a été publié dans

Revue des Maladies Respiratoires. 2021-01, vol. 38, n° 1, p. 114-121

Résumé en anglais

The French-speaking Respiratory Medicine Society (SPLF) proposes a guide for the management of possible respiratory sequelae in patients who have presented with SARS-CoV-2 pneumonia (COVID-19). The proposals are based on known data from previous epidemics, preliminary published data on post COVID-19 follow-up and on expert opinion. The proposals were developed by a group of experts and then submitted, using the Delphi method, to a panel of 22 pulmonologists. Seventeen proposals were validated ranging from additional examinations after the minimum assessment proposed in the SPLF monitoring guide, to inhaled or systemic corticosteroid therapy and antifibrotic agents. These proposals may evolve over time as knowledge accumulates. This guide emphasizes the importance of multidisciplinary discussion.< Réduire

Métadonnées

Partager cette publication !

Licence d’utilisation du document